Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2022

Joint ESMO-SITC Immunotherapy Primer

The microbiome influence on the TME

Date

07 Dec 2022

Session

Joint ESMO-SITC Immunotherapy Primer

Topics

Tumour Immunology;  Immunotherapy

Tumour Site

Genitourinary Cancers;  Thoracic Malignancies

Presenters

Laurence Zitvogel

Authors

L. Zitvogel

Author affiliations

  • Institut Gustave Roussy, Villejuif/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: To be Announced

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Webcast

Q&A

Presenter: Tullia Bruno

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Webcast

Q&A

Presenter: Tullia Bruno

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Webcast

Q&A

Presenter: Tullia Bruno

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Webcast

Stromal cells in the TME

Presenter: Lan Gardner Coffman

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Slides

Webcast

Q&A

Presenter: Tullia Bruno

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Webcast

Panel session

Presenter: Tullia Bruno

Session: Joint ESMO-SITC Immunotherapy Primer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.